DWQA Questions › Tag: EMA
Filter:AllOpenResolvedClosedUnanswered
The diabetes drug rosiglitazone, sold under the trade name Avandia, has come under scrutiny. From 1999 to 2009, nearly 50,000 people on Avandia suffered heart attack, stroke, heart failure or death. In Europe, the European Medicines Agency (EMA) recommended in September 2010 that the drug be suspended because the benefits no longer outweighed the risks.[10][11] It was withdrawn from the market in the UK, Spain and India in 2010,[12] and in New Zealand and South Africa in 2011. It is still being prescribed in the U.S. following a review of safety data by the FDA. Is this drug safe to use or are there cardiovascular risks? What is Creator’s perspective?
ClosedNicola asked 2 days ago • 
8 views0 answers0 votes
Ask Question